Tumor Markers Screen (Male)
850,00 د.إ
Tumor Markers Screen (Male) is a comprehensive 6-parameter surveillance system. By analyzing specific biomarkers in your blood, CA 19.9, CEA, PSA-Total, PSA-Free, AFP, and BhCG, this panel offers a panoramic view of your cancer risk.
Sample Type : Serum
Methodology : Chemiluminescence
TAT : 1 Day
Description
Tumor Markers Screen (Male) – (CA 19.9, CEA, PSA-Total, PSA-Free, AFP, BhCG)
We often treat our bodies like machines that are built to last indefinitely. We ignore the rattles, the leaks, and the warning lights until the engine seizes. But when it comes to cancer, the “check engine” light rarely comes on until the damage is already done.
For men, the statistics are sobering. Prostate cancer, colorectal cancer, and liver cancer are among the leading causes of death worldwide, often remaining silent in their early, most treatable stages.
This is where the Tumor Markers Screen (Male) steps in. It is not a single test, but a comprehensive 6-parameter surveillance system. By analyzing specific biomarkers in your blood, CA 19.9, CEA, PSA-Total, PSA-Free, AFP, and BhCG, this panel offers a panoramic view of your cancer risk. It is the ultimate tool for the proactive man who refuses to leave his health to chance.
Why a “Screen” is Better Than a “Shot in the Dark”
Many men only get tested when they feel pain. But cancer pain is a late symptom. By the time you feel a tumor, it has often grown large enough to press on nerves or organs.
This screen is designed to catch the biochemical signals before the physical symptoms appear. It covers the “Big Three” areas of concern for men:
- The Prostate: Using the Gold Standard of PSA testing.
- The Digestive Tract: Screening for pancreatic and colorectal cancers.
- The Reproductive System & Liver: Detecting testicular cancer and liver malignancies.
Decoding the Six Guardians
To understand the power of this test, you have to understand the guardians it deploys.
1. The Prostate Duo: PSA-Total & PSA-Free Prostate-Specific Antigen (PSA) is the gold standard for prostate health. However, looking at just the “Total” number can be misleading. Benign conditions like an enlarged prostate can elevate PSA. This test refines the view by measuring PSA-Free.
- Why it matters: The ratio of Free PSA to Total PSA helps doctors distinguish between benign prostate enlargement and aggressive prostate cancer, reducing the need for unnecessary biopsies.
2. The Gut Check: CA 19.9 & CEA
- CA 19.9: This marker is closely associated with pancreatic cancer and biliary tract cancers. Pancreatic cancer is notoriously difficult to detect early; CA 19.9 is one of the few tools we have to catch it early.
- CEA (Carcinoembryonic Antigen): While present in fetal development, elevated levels in adults are a red flag for colorectal cancer. It helps monitor for recurrence in patients who have had previous cancer treatment.
3. The Fetal Echoes: AFP & BhCG
- AFP (Alpha-Fetoprotein): Normally produced by a fetus, high levels in an adult male are a warning sign for liver cancer (hepatocellular carcinoma) or testicular cancer.
- BhCG (Beta-Human Chorionic Gonadotropin): Most famous as a pregnancy test, BhCG in men is a critical marker for testicular cancer. If this hormone is present in a male bloodstream, it demands immediate investigation.
The Body’s Distress Signals
While the Tumor Markers Screen (Male) test is designed for early detection, you should definitely prioritize it if you are experiencing any of the following:
- Urinary Changes: Difficulty urinating, a weak stream, or frequent urges (especially at night).
- Abdominal Warning Signs: Persistent pain, unexplained weight loss, changes in bowel habits, or blood in the stool.
- Physical Changes: Testicular pain, swelling, or the feeling of a lump.
- Systemic Red Flags: Jaundice (yellowing of the eyes/skin), fatigue that won’t go away, or night sweats.
These are not just signs of “getting older.” They are biological warrants for investigation.
The Cost of Silence
The most dangerous strategy is “watchful waiting” without data. Ignoring these potential risks allows cancer to progress from a localized, treatable issue to a systemic, metastatic nightmare.
- Prostate Cancer: If untreated, it can spread to the bones and cause severe pain and fractures.
- Gastrointestinal Cancers: Cancers of the pancreas and colon can lead to bowel obstruction, sepsis, and organ failure.
- Testicular Cancer: While highly treatable, ignoring it allows it to spread to the lymph nodes and lungs.
This screen provides the opportunity to intervene while the odds are still in your favor.
How to Prepare for Precision
To ensure that the biomarkers in your blood provide a clear picture, a small amount of preparation is required. You are essentially clearing the static to hear the signal.
Preparation Guidelines:
- Fasting: Fast for 8–12 hours before the test. This ensures that recent dietary intake doesn’t skew the metabolic markers.
- Dietary Restrictions: Avoid alcohol and fatty foods for at least 24 hours prior.
- Medication Review: Inform your doctor about any supplements or medications you are taking.
- Timing: Schedule the test in the morning for the most accurate hormonal baselines.
The Technology: Chemiluminescence
This isn’t a standard dipstick test. The lab uses Chemiluminescence, a highly sensitive analytical technique that uses light emission to measure the concentration of tumor markers. This technology provides the precision needed to detect even subtle elevations that older methods might miss.
Test Overview:
- Sample Type: Serum
- Methodology: Chemiluminescence
- Turnaround Time (TAT): 1 Day
Empower Your Health Future
Knowledge is the antidote to fear. Many men fear the doctor’s office because they are afraid of what they might find. But the true danger is the unknown.
The Tumor Markers Screen (Male) gives you the data you need to take control. Whether you have a family history of cancer, you are over the age of 40, or you simply want to baseline your health, this screen is an act of self-respect.
Don’t wait for symptoms to force your hand.
Take charge today. Book your lab test online to schedule your Tumor Markers Screen. It’s a simple blood draw that offers the ultimate return on investment: peace of mind and a longer, healthier life.
Frequently Asked Questions – Male Tumor Markers Screen
What tumor markers are included in this panel?
This comprehensive male cancer screening panel includes six key biomarkers:
– PSA (Total and Free): Prostate health
– CEA (Carcinoembryonic Antigen): Colorectal, lung, and other cancers
– CA 19-9: Pancreatic, biliary, and gastrointestinal cancers
– AFP (Alpha-Fetoprotein): Liver and germ cell tumors
– Beta-hCG: Testicular and germ cell cancers
Can this test diagnose cancer?
No. This is a screening and monitoring tool, not a diagnostic test. Elevated markers may indicate cancer, but can also be caused by benign conditions like prostatitis, liver inflammation, smoking, or infection. Abnormal results should always be followed up with imaging (ultrasound, MRI, CT) or biopsy by a specialist.
Who should take this Tumor Markers Screen (Male) test?
This panel is recommended for:
– Men over 40 with a family history of prostate, pancreatic, or colorectal cancer
– Individuals with unexplained weight loss, abdominal pain, or changes in bowel habits
– Men with testicular lumps or hormonal symptoms
– Those in post-treatment monitoring for known cancers
– Health-conscious men seeking early-risk awareness
Do I need to fast before the Tumor Markers Screen (Male) test?
Yes. Please fast for 8–12 hours (water allowed) before your blood draw. Avoid ejaculation for 48 hours prior to PSA testing, as it can temporarily elevate levels. Inform your provider about supplements, medications, or recent procedures.
How soon will I get my results?
Thanks to Chemiluminescence Immunoassay (CLIA) methodology, results are typically available within 24–48 hours. You’ll receive a secure digital report with all values, reference ranges, and clinical notes, ideal for sharing with your urologist, oncologist, or primary care doctor.
Why include both Total and Free PSA?
The Free/Total PSA ratio helps distinguish between benign prostate enlargement (BPH) and prostate cancer. A low percentage of free PSA (<10–15%) increases suspicion for cancer, even if total PSA is only mildly elevated. This reduces unnecessary biopsies and improves diagnostic accuracy.





Reviews
There are no reviews yet.